Sickle cell disease and venous thromboembolism: what the anticoagulation expert needs to know
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cardiology and Cardiovascular Medicine,Hematology
Link
http://link.springer.com/content/pdf/10.1007/s11239-013-0895-y.pdf
Reference62 articles.
1. Bunn HF (1997) Pathogenesis and treatment of sickle cell disease. N Engl J Med 337(11):762–769
2. Famodu AA, Oduwa D (1995) Platelet count and platelet factor 3 (PF-3) availability in sickle cell disease. Br J Biomed Sci 52(4):323–324
3. Foulon I, Bachir D, Galacteros F, Maclouf J (1993) Increased in vivo production of thromboxane in patients with sickle cell disease is accompanied by an impairment of platelet functions to the thromboxane A2 agonist U46619. Arterioscler thromb 13(3):421–426
4. Kenny MW, George AJ, Stuart J (1980) Platelet hyperactivity in sickle-cell disease: a consequence of hyposplenism. J Clin Pathol 33(7):622–625
5. Westerman M, Pizzey A, Hirschman J et al (2008) Microvesicles in haemoglobinopathies offer insights into mechanisms of hypercoagulability, haemolysis and the effects of therapy. Br J Haematol 142(1):126–135
Cited by 88 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Multicenter, phase 1 study of etavopivat (FT-4202) treatment for up to 12 weeks in patients with sickle cell disease;Blood Advances;2024-08-27
2. Prevention and management of indwelling catheter‐related thrombosis in sickle cell disease and thalassaemia: A British Society for Haematology Good Practice Paper;British Journal of Haematology;2024-07-31
3. Hospital acquired venous thromboembolism in children with sickle cell disease;Pediatric Hematology and Oncology;2024-06-05
4. Disease severity drives risk of venous thrombotic events in women with sickle cell disease in a single-center retrospective study;Research and Practice in Thrombosis and Haemostasis;2024-05
5. Chronic kidney disease and outcomes in hospitalized sickle cell disease patients: A National Inpatient Sample analysis;European Journal of Haematology;2024-03-21
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3